Ken Griffin Mimedx Group, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 8,000 shares of MDXG stock, worth $72,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,000

Previous 34,600 76.88%

Holding current value

$72,800

Previous $239,000 80.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.65 - $7.76 $2.29 Million - $3.15 Million	405,648 Added 1005.95%	445,973 $2.64 Million
Q2 2024 Aug 14, 2024	BUY	$6.16 - $8.08 $248,402 - $325,826	40,325 New	40,325 $279,000
Q4 2023 Feb 14, 2024	SELL	$5.7 - $9.14 $665,144 - $1.07 Million	-116,692 Reduced 99.38%	724 $6,000
Q3 2023 Nov 14, 2023	SELL	$6.35 - $8.16 $565,492 - $726,680	-89,054 Reduced 43.13%	117,416 $855,000
Q2 2023 Aug 14, 2023	SELL	$3.14 - $6.61 $338,400 - $712,366	-107,771 Reduced 34.3%	206,470 $1.36 Million
Q1 2023 May 15, 2023	BUY	$2.97 - $4.81 $465,820 - $754,410	156,842 Added 99.65%	314,241 $1.07 Million
Q4 2022 Feb 14, 2023	BUY	$2.63 - $3.45 $269,062 - $352,952	102,305 Added 185.69%	157,399 $437,000
Q3 2022 Nov 14, 2022	SELL	$2.71 - $4.22 $136,047 - $211,852	-50,202 Reduced 47.68%	55,094 $158,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $5.0 $792,103 - $1.25 Million	-249,875 Reduced 70.35%	105,296 $365,000
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $354,721 - $520,867	83,073 Added 30.53%	355,171 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$5.7 - $8.48 $1.11 Million - $1.65 Million	194,217 Added 249.38%	272,098 $1.64 Million
Q3 2021 Nov 15, 2021	BUY	$5.52 - $15.83 $353,644 - $1.01 Million	64,066 Added 463.74%	77,881 $472,000
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.72 $2.68 Million - $3.78 Million	-297,451 Reduced 95.56%	13,815 $172,000
Q1 2021 May 17, 2021	BUY	$8.48 - $11.28 $1.94 Million - $2.58 Million	228,854 Added 277.69%	311,266 $3.21 Million
Q4 2020 Feb 16, 2021	SELL	$5.32 - $10.17 $224,259 - $428,706	-42,154 Reduced 33.84%	82,412 $748,000
Q3 2018 Nov 13, 2018	BUY	$3.22 - $6.33 $168,470 - $331,185	52,320 Added 72.42%	124,566 $0
Q4 2017 Feb 09, 2018	SELL	$10.87 - $13.9 $3.31 Million - $4.23 Million	-304,057 Reduced 80.8%	72,246 $911,000
Q3 2017 Nov 09, 2017	BUY	$11.86 - $17.34 $4.46 Million - $6.53 Million	376,303	376,303 $4.47 Million

Others Institutions Holding MDXG

# of Institutions

208

Shares Held

98.1M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account